Marc‐Oliver Grimm
Brigham and Women's Hospital
1 paper in the Anchorcite directory, published in 2018, cited 4,757 times in total.
ORCID profileResearch topics
- Cancer Immunotherapy and Biomarkers · 1 paper
- Renal cell carcinoma treatment · 1 paper
- Ferroptosis and cancer prognosis · 1 paper
Frequent co-authors
- Robert John Motzer · 1 paper
- Nizar M. Tannir · 1 paper
- David F. McDermott · 1 paper
- Osvaldo Arén Frontera · 1 paper
- Bohuslav Melichar · 1 paper
- Toni K. Choueiri · 1 paper
- Elizabeth R. Plimack · 1 paper
- Philippe Barthélémy · 1 paper
Papers
- Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell CarcinomaNew England Journal of Medicine · 2018 · 4,757 citations
BACKGROUND: Nivolumab plus ipilimumab produced objective responses in patients with advanced renal-cell carcinoma in a pilot study. This phase 3 trial compared nivolumab plus ipilimumab with sunitinib for previously untreated clear-cell advanced renal-cell carcinoma. METHODS: We randomly assigned adults in…
Metadata from OpenAlex (CC0).